Richard Paul Bryce's Net Worth
$4.66 Million
Who is Richard Paul Bryce?
Richard Paul Bryce has an estimated net worth of $4.66 Million. This is based on reported shares across multiple companies, which include PUMA BIOTECHNOLOGY, INC., Rain Therapeutics Inc., and enGene Holdings Inc..
SEC CIK
Richard Paul Bryce's CIK is 0001553037
Past Insider Trading and Trends
2017 was Richard Paul Bryce's most active year for acquiring shares with 5 total transactions. Richard Paul Bryce's most active month to acquire stocks was the month of January. 2019 was Richard Paul Bryce's most active year for disposing of shares, totalling 14 transactions. Richard Paul Bryce's most active month to dispose stocks was the month of June. 2017 saw Richard Paul Bryce paying a total of $395,500.00 for 66,500 shares, this is the most they've acquired in one year. In 2017 Richard Paul Bryce cashed out on 74,291 shares for a total of $4,001,885.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $2.25
SEE REMARKS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.35% | -426.00 |
$9.80 | -$4,176.04 | 121.66K |
Apr 5
| |||
Form 4
| -0.34% | -422.00 |
$10.15 | -$4,283.30 | 122.09K |
Mar 2
| |||
Form 4
| +75.86% | 52.85K |
—
|
—
| 122.51K |
Feb 17
| |||
Form 4
| -0.59% | -415.00 |
$12.23 | -$5,075.95 | 69.66K |
Feb 2
| |||
Form 4
| -8.55% | -6.55K |
$10.23 | -$67,016.16 | 70.08K |
Jan 4
| |||
Form 4
| -0.12% | -92.00 |
$11.65 | -$1,071.80 | 76.63K |
Dec 2
| |||
Form 4
| -0.13% | -97.00 |
$7.81 | -$757.57 | 76.72K |
Nov 2
| |||
Form 4
| -0.12% | -91.00 |
$10.14 | -$923.10 | 76.82K |
Oct 2
| |||
Form 4
| -0.12% | -90.00 |
$9.77 | -$879.30 | 76.91K |
Sep 2
| |||
Form 4
| -0.11% | -86.00 |
$10.80 | -$928.80 | 77K |
Aug 3
| |||
Form 4
| -0.85% | -660.00 |
$10.67 | -$7,040.42 | 77.08K |
Jul 2
| |||
Form 4
| -0.11% | -89.00 |
$10.66 | -$948.74 | 77.74K |
Jun 2
| |||
Form 4
| -0.11% | -89.00 |
$9.62 | -$856.19 | 77.83K |
May 4
| |||
Form 4
| -0.12% | -91.00 |
$7.37 | -$670.68 | 77.92K |
Apr 2
| |||
Form 4
| -0.12% | -96.00 |
$10.02 | -$962.15 | 78.01K |
Mar 2
| |||
Form 4
| +124.23% | 43.27K |
—
|
—
| 78.11K |
Feb 11
| |||
Form 4
| -0.30% | -105.00 |
$8.02 | -$841.57 | 34.83K |
Feb 3
| |||
Form 4
| -4.16% | -1.52K |
$8.40 | -$12,734.32 | 34.94K |
Jan 2
| |||
Form 4
| -0.23% | -83.00 |
$10.34 | -$858.23 | 36.45K |
Dec 2
| |||
Form 4
| -0.24% | -88.00 |
$7.38 | -$649.45 | 36.54K |
Nov 4
| |||
Form 4
| -0.25% | -91.00 |
$10.05 | -$914.55 | 36.63K |
Oct 2
| |||
Form 4
| -0.26% | -95.00 |
$10.11 | -$960.45 | 36.72K |
Sep 4
| |||
Form 4
| -0.25% | -94.00 |
$9.00 | -$846.00 | 36.81K |
Aug 2
| |||
Form 4
| -4.75% | -1.84K |
$10.10 | -$18,588.76 | 36.91K |
Scheduled
|
Jul 22
| ||
Form 4
| -0.23% | -89.00 |
$12.78 | -$1,137.42 | 38.75K |
Jul 2
| |||
Form 4
| -0.23% | -88.00 |
$15.07 | -$1,326.16 | 38.84K |
Jun 3
| |||
Form 4
| -0.22% | -85.00 |
$32.38 | -$2,752.31 | 38.92K |
May 2
| |||
Form 4
| -0.23% | -88.00 |
$35.78 | -$3,148.65 | 39.01K |
Apr 2
| |||
Form 4
| -0.22% | -88.00 |
$38.66 | -$3,402.08 | 39.1K |
Mar 4
| |||
Form 4
| +33.81% | 9.9K |
—
|
—
| 39.19K |
Feb 6
| |||
Form 4
| -0.30% | -89.00 |
$27.77 | -$2,471.53 | 29.29K |
Feb 4
| |||
Form 4
| -6.25% | -1.96K |
$24.72 | -$48,426.48 | 29.37K |
Scheduled
|
Jan 22
| ||
Form 4
| -3.72% | -1.21K |
$20.67 | -$25,010.70 | 31.33K |
Jan 3
| |||
Form 4
| -5.34% | -1.84K |
$51.95 | -$95,381.30 | 32.54K |
Scheduled
|
Jul 20
| ||
Form 4/A
| +35.46% | 9K |
—
|
—
| 34.38K |
Feb 11
| |||
Form 4
| -20.75% | -9.00K |
—
|
—
| 34.38K |
Feb 11
| |||
Form 4
| -6.83% | -1.86K |
$92.75 | -$172,515.00 | 25.38K |
Scheduled
|
Jan 22
| ||
Form 4
|
—
|
0
|
$65.65 | -$1,630,500.00 | 27.24K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
$55.70 | -$1,331,900.00 | 27.24K |
Scheduled
|
Sep 6 - Sep 7
| ||
Form 4
| -6.83% | -2.00K |
$94.48 | -$188,777.28 | 27.24K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
$49.20 | -$379,000.00 | 29.24K |
Scheduled
|
Jul 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -7.27% | -2.29K |
$33.24 | -$76,208.08 | 29.24K |
Scheduled
|
Jan 20
| ||
Form 4
| +105,000.00% | 31.5K |
—
|
—
| 31.53K |
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
$60.67 | -$296,184.00 | 30 |
Scheduled
|
Jul 6
| ||
Form 4
|
∞
| 30 |
$82.81 | $2,484.42 | 30 |
Apr 9 - Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rain Therapeutics Inc. (RAIN) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
enGene Holdings Inc. (ENGN) Snapshot price: $7
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |